Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lipella Pharmaceuticals, Inc. ( (LIPO) ) has shared an announcement.
On February 3, 2026, Lipella Pharmaceuticals Inc. announced that board member Lori A. Birder resigned from the company’s Board of Directors, effective immediately. The company stated that her resignation was not the result of any disagreement over Lipella’s operations, policies, or practices, suggesting no underlying governance dispute or operational conflict tied to her departure.
The most recent analyst rating on (LIPO) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Lipella Pharmaceuticals, Inc. stock, see the LIPO Stock Forecast page.
More about Lipella Pharmaceuticals, Inc.
Average Trading Volume: 11,721
Technical Sentiment Signal: Sell
Current Market Cap: $1.02M
See more data about LIPO stock on TipRanks’ Stock Analysis page.